Isolated Systolic Hypertension
1 competing product in clinical development for Isolated Systolic Hypertension.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| olmesartan medoxomil + hydrochlorothiazide, if necessary + nitrendipine + hydrochlorothiazide, if necessary | Daiichi Sankyo | Phase 3 | Completed | 40 |